New Legislation Would Cut Off Access To The Courts And Immunize FDA Actions From Timely Judicial Review
The FDA Law Blog
APRIL 30, 2023
Senate Committee on Health, Education, Labor and Pensions (“Senate HELP”) is scheduled to take up legislation that could significantly limit access to the courts and immunize critical FDA decisions from timely judicial review. 110-316 (2008) and by Section 1135 of the FDA Safety and Innovation Act (“FDASIA”), Pub. That bill is S.
Let's personalize your content